Who
Eric Dozier
EVP, Chief People Officer
Company insider
Files Form 4 as: EVP, Chief People Officer, Eli Lilly and.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Feb 2023
- Last trade
- 2 Sep 2026
- Last filed
- 4 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Sep 2026filed 4 Sep 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —216 at $0.00 | filing |
| 2 Sep 2026filed 4 Sep 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —216 at $0.00 | filing |
| 19 Feb 2026filed 19 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —481 at $0.00 | filing |
| 19 Feb 2026filed 19 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —481 at $0.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $3.7M3,512.294 at $1,044.67 | filing |
| 9 Feb 2026filed 11 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $3.7M3,512.29 at $1,044.67 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —2,858 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $1.3M1,272.992 at $1,037.15 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,858 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,858 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —2,858 at $0.00 | filing |
| 1 Feb 2026filed 3 Feb 2026 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $1.3M1,272.99 at $1,037.15 | filing |
| 1 Mar 2025filed 3 Mar 2025 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —2,403 at $0.00 | filing |
| 1 Mar 2025filed 3 Mar 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —2,403 at $0.00 | filing |
| 1 Mar 2025filed 3 Mar 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code F | $982K1,066.21 at $920.63 | filing |
| 20 Feb 2025filed 21 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code G | —460 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,858 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code A | $799K919.53 at $868.88 | filing |
| 1 Nov 2024filed 5 Nov 2024 | LLY Eli Lilly andoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —1,534 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | LLY Eli Lilly andPharmaceuticals | SEC FORM 4 Code M | —1,534 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.